EBR Systems, Inc. Reports Strong Q1 2026 Growth in Commercial Cases and Preliminary Financial Results

EBR Systems, Inc. announced its commercial progress and preliminary financial results for the first quarter ended March 31, 2026. The company experienced significant growth in commercial cases, with case volumes more than doubling from the previous quarter. The WiSE® System was implanted in 41 commercial patients in Q1 2026, bringing the total to 71 implants across the pilot phase and Limited Market Release. EBR Systems expects to report revenue between US$2.25M and US$2.36M for Q1 2026, based on preliminary unaudited results. The Limited Market Release also advanced with 16 new purchase agreements signed and 22 additional physicians trained. The company also announced a 1-for-10 reverse stock split, effective April 1, 2026. EBR Systems will host an investor webinar on April 10, 2026, to discuss the Q1 results.